Cologne, Germany
Niostem, formerly known as Mane Biotech, is a B2C hardware startup founded in 2019 and headquartered in Germany. The company's mission is to develop innovative technologies that unleash the body’s regenerative potential, ultimately enabling customers to lead healthier lives. Specifically, Niostem is tackling common hair loss and pattern baldness with its flagship product, the nio1 smart wearable device. This groundbreaking solution is designed to not only halt hair loss within 3 months but also support hair regrowth in 6 months.
The company recently secured a significant €1.70M Seed Round investment on 18 January 2022, with the backing of Brightlands Venture Partners. This injection of funds speaks to the potential and promise that Niostem holds in the industry, and it's a strong indication of investor confidence in the startup's innovative approach to addressing common health issues through technological advancements.
